Few areas of law generate as many practical questions as patents. An inventor who has spent years perfecting a product suddenly faces a thicket of unfamiliar terms—nonprovisional, prior art, office action, maintenance fee, PCT national phase—and a federal agency with its own forms, deadlines, and procedures. The U.S. Patent and Trademark Office (USPTO) publishes a set of frequently asked questions to help, but those answers are often terse, occasionally outdated, and rarely explain why the rules are what they are.

This guide takes the most common USPTO patent questions and answers them properly. It is organized into themed sections—patentability, application types, the prosecution process, costs and fees, provisional applications, international filing, post-grant review, term and maintenance, ownership, and enforcement—so you can read straight through or jump to what you need. Throughout, we cite the governing statutes (Title 35 of the U.S. Code) and regulations (Title 37 of the Code of Federal Regulations), explain the America Invents Act's first-inventor-to-file rule, and work through concrete examples using invented parties (for instance, "Acme Corp." and inventor "Dana Lee") so that the abstractions become tangible. The aim is a single, reliable reference an inventor, a founder, and a practicing attorney can all use with confidence.

How this guide fits with our other patent resources

mclaw.io publishes two patent FAQs on purpose, because the questions inventors ask fall into two very different moods. This article is the procedural one—the keyboard-side reference for how the USPTO actually works: filing, prosecution, fees, deadlines, and Patent Office practice. Its companion, Patent FAQs: Frequently Asked Questions About Patents, is the coffee-table version: it answers the upstream, decision-making questions—Do I even need a patent? Should I file? What will this cost me, and is it worth it?—in plain English with minimal jargon. If you are not yet sure whether patenting is the right move, start there and come back here once you have decided to file. If you want the gentlest possible introduction to the whole subject, read Patent Basics: A Plain-English Guide; for the broad, soup-to-nuts overview that pulls the pieces together, see General Information Concerning Patents; and for a focused treatment of the most common patent type, see Utility Patent Basics. This article assumes you have made the threshold decision and want to understand the machinery.

A word of orientation before we begin: a patent is a creature of federal statute. There is no such thing as a state patent, and the rights a U.S. patent confers stop at the U.S. border. Everything below flows from that statutory framework and from the agency Congress charged with administering it.

What a Patent Is and What It Is Not

What is a patent? A patent is a limited-duration property right in an invention, granted by the federal government in exchange for the inventor's full public disclosure of how the invention works. The operative grant, codified at 35 U.S.C. § 154(a)(1), gives the patent owner the right "to exclude others from making, using, offering for sale, or selling the invention throughout the United States or importing the invention into the United States." Note the framing carefully: a patent is a right to exclude, not a right to practice. Owning a patent does not guarantee you may sell your own product—someone else's earlier patent might block you—which is precisely why a separate freedom-to-operate analysis is a distinct and important exercise from obtaining your own patent.

A patent is a bargain. The Constitution authorizes Congress "[t]o promote the Progress of Science and useful Arts, by securing for limited Times to … Inventors the exclusive Right to their … Discoveries" (U.S. Const. art. I, § 8, cl. 8). The "limited time" is the exclusivity; the "promotion of progress" is the disclosure, which enters the public domain when the patent expires and which others may study and design around in the meantime. The Supreme Court has called this disclosure "the quid pro quo of the right to exclude" (Kewanee Oil Co. v. Bicron Corp., 416 U.S. 470, 484 (1974)). You cannot patent a mere idea, hope, or suggestion. You must describe a concrete, workable invention in enough detail that a person skilled in the relevant field could make and use it.

Who can apply for a patent? Under U.S. law a patent application must be made in the name of the actual inventor or inventors—the human being or beings who conceived the invention. Conception, not funding and not labor, is the touchstone. This rule has a hard edge that surprises many people. If Dana Lee conceives a new valve design and persuades a wealthy friend, Morgan, to pay for the prototype, Morgan is not a co-inventor merely for having written the checks. Likewise, a machinist who builds exactly what Dana specified, exercising no inventive judgment, is not an inventor. As the USPTO has long put it, the application is filed by the person who furnishes the ideas, not the employer or the person who furnishes the money. The Federal Circuit has also made clear that an inventor must be a natural person: an artificial-intelligence system cannot be named as an inventor (Thaler v. Vidal, 43 F.4th 1207 (Fed. Cir. 2022)), a holding with growing practical importance that we explore in AI-Generated Inventions: Who Owns What the Machine Creates. (Ownership is a separate matter—an employer often owns the resulting patent by assignment even though only the human inventor can be named; we return to that distinction below.)

Who are joint inventors? When two or more people each contribute to the conception of at least one claim, they are joint inventors and the patent issues to them jointly. Importantly, joint inventors need not have worked at the same time, made the same type or amount of contribution, or contributed to every claim (35 U.S.C. § 116(a)). A contribution to a single claim is enough. But a person who merely follows another's instructions, or who contributes only ordinary skill rather than inventive insight, is not a co-inventor. Getting inventorship right is not a formality: naming a person who did not invent, or omitting one who did, can render a patent unenforceable unless the error is corrected without deceptive intent under 35 U.S.C. § 256, and disputes over inventorship are a recurring source of litigation. Because inventorship is determined claim-by-claim, it can shift as claims are amended during prosecution.

What do "patent pending" and "patent applied for" mean? These phrases tell the public that a patent application covering the article is on file at the USPTO. They confer no enforceable rights by themselves—you cannot sue for infringement until a patent actually issues—but they put competitors on notice and may deter copying. The terms are not decorative. Using "patent pending" when no application is on file, or marking a product as patented when it is not, is false marking, which can carry liability under 35 U.S.C. § 292; since the AIA, a private plaintiff must show a competitive injury to recover, but the government and the marked-out public still have remedies. For the related but distinct question of how and when to mark products that are covered by an issued patent, see our practical guide to patent marking requirements; proper marking is what allows a patentee to recover pre-suit damages under § 287.

Patentability: What Can and Cannot Be Patented

What can be patented? The Patent Act recognizes three kinds of patents. A utility patent (35 U.S.C. § 101) may be granted to anyone who invents or discovers a new and useful process, machine, article of manufacture, or composition of matter, or any new and useful improvement of one of those. A design patent (35 U.S.C. § 171) protects a new, original, and ornamental design for an article of manufacture—the way a thing looks rather than how it works. A plant patent (35 U.S.C. § 161) protects a distinct and new variety of plant that has been asexually reproduced. The overwhelming majority of patents are utility patents, and most of this guide addresses them; for the fundamentals of that workhorse category, see Utility Patent Basics.

What cannot be patented? Courts have carved three judicial exceptions out of § 101: laws of nature, natural phenomena, and abstract ideas. Alice Corp. v. CLS Bank International, 573 U.S. 208 (2014), set the prevailing two-step test for these exceptions: first, determine whether the claim is directed to one of the excepted categories; if so, ask whether the claim contains an "inventive concept" sufficient to transform it into a patent-eligible application of the idea rather than a claim on the idea itself. This framework, building on Mayo Collaborative Services v. Prometheus Laboratories, 566 U.S. 66 (2012), is the central battleground for software, diagnostics, and business-method inventions. If your invention lives in that space, read our detailed treatment of patent eligibility after Alice, which explains how to draft claims that recite a concrete technological improvement rather than a disembodied idea. Separately, you cannot patent things that are not useful (the classic example is a perpetual-motion machine, which fails the utility requirement because it cannot work), and literary, dramatic, musical, and artistic works belong to copyright rather than patent law. For the broader map of how these regimes divide up the territory, see Copyright vs. Trademark: What Is the Difference and our copyright companion, Copyright FAQs: Answers to Common Copyright Questions.

What are the substantive requirements? Beyond eligible subject matter, a utility invention must clear four hurdles:

  1. Utility (§ 101): the invention must have a specific, substantial, and credible use.
  2. Novelty (§ 102): the invention must be new—not already disclosed in the prior art.
  3. Nonobviousness (§ 103): the differences between the invention and the prior art must be such that the invention as a whole would not have been obvious to a person of ordinary skill in the art at the time. This is where the most applications fail. The framework comes from Graham v. John Deere Co., 383 U.S. 1 (1966), and KSR International Co. v. Teleflex Inc., 550 U.S. 398 (2007), which rejected a rigid "teaching, suggestion, or motivation" test in favor of an "expansive and flexible" inquiry. Because obviousness rejections are so common and so consequential, we devote an entire guide to overcoming obviousness rejections under Section 103.
  4. Adequate disclosure (§ 112): the specification must describe the invention in writing (written description), enable a skilled person to make and use it (enablement), and conclude with claims that particularly point out and distinctly claim the subject matter regarded as the invention (definiteness). On that last point, a claim is indefinite if, read in light of the specification and prosecution history, it fails to inform a skilled artisan "with reasonable certainty" about the scope of the invention (Nautilus, Inc. v. Biosig Instruments, Inc., 572 U.S. 898 (2014)). Enablement, in turn, must cover the full scope of what is claimed (Amgen Inc. v. Sanofi, 598 U.S. 594 (2023)).

How do I know whether my invention is patentable? Start by confirming that your invention falls within an eligible category and is useful. Then, because novelty and nonobviousness turn on what already exists, conduct a prior-art search. "Prior art" means earlier public disclosures—issued patents, published applications, printed publications, products on the market, and public uses—anywhere in the world (35 U.S.C. § 102(a)). A search is not legally required before filing, but it is almost always advisable: it tells you whether the field is crowded, helps you draft claims around what already exists, and can save the substantial cost of prosecuting an application that was doomed from the start. You can search the USPTO's full-text databases (the modern Patent Public Search tool covers patents from 1790 forward, full text from 1976), and you can get free in-person help at a Patent and Trademark Resource Center (PTRC)—a nationwide network of public, state, and academic libraries; you do not have to travel to Alexandria, Virginia, to search. For anything beyond a preliminary look, a registered patent attorney or agent who commissions a professional search will give you a far more reliable picture. One caution the USPTO rightly emphasizes: finding nothing in your own search does not prove your invention is new. Searches are imperfect, and some prior art (such as recently filed but unpublished applications) is not yet visible.

Application Types and How to Apply

How do I apply for a patent? There are two routes into the system. A nonprovisional application is the real thing—it is examined on the merits and can mature into a granted patent. A provisional application is a placeholder that secures an early filing date but is never examined and never becomes a patent on its own. Both can be filed electronically through the USPTO's Patent Center, and the USPTO strongly recommends electronic filing: paper applications incur a non-electronic-filing surcharge under 37 C.F.R. § 1.16(t), and an electronically filed application receives its application number within minutes. You generally cannot fax a patent application, and although you may hand-deliver one to the USPTO's customer window in Alexandria, virtually all applicants file online.

A nonprovisional utility application must include a specification (a written description plus at least one claim), any drawings necessary to understand the invention, an oath or declaration by each inventor (35 U.S.C. § 115), and the required fees. The claims are the legally operative part: they define the metes and bounds of the right to exclude, the way a deed's legal description defines a parcel of land. Everything else in the application exists to support the claims. A missing claim or the omission of the filing fee will not necessarily forfeit the filing date for a nonprovisional, but it will trigger a notice to file missing parts and additional fees—another reason to file complete.

What is the difference between a disclosure document and a provisional application? This question reflects an older practice. The USPTO's Disclosure Document Program—a mechanism for filing evidence of conception—was discontinued in 2007, in part because the provisional application made it largely redundant. The key conceptual point survives, however: a provisional application is a real patent application that establishes an official U.S. filing date and lets you mark products "patent pending," whereas a mere disclosure of your idea (to yourself, a notebook, or a private service) does neither. A provisional automatically expires twelve months after its filing date, and to capture its benefit you must file a corresponding nonprovisional (or a national-phase or PCT application claiming its priority) before that period runs (35 U.S.C. § 111(b); 35 U.S.C. § 119(e)).

Continuing applications—continuation, divisional, continuation-in-part. Once you have a nonprovisional on file, you can spawn related applications that keep the original filing date for shared subject matter (35 U.S.C. § 120). A continuation pursues additional claims to the same invention disclosed in the parent. A divisional carves out a distinct invention the examiner required you to separate (a "restriction requirement" under § 121). A continuation-in-part (CIP) adds new matter to the original disclosure—but be careful: claims that rely on the new matter get only the later CIP filing date, not the parent's, for prior-art purposes. These tools let applicants keep a family alive for years, refining claim scope as the market and competitors' products develop. Used well, a continuation strategy is one of the most valuable levers in patent portfolio management; used carelessly, a chain of continuations can expose the family to obviousness-type double patenting and the need for a terminal disclaimer.

What is prioritized examination ("Track One")? Ordinary examination takes time—USPTO pendency commonly runs around two years and can be longer in crowded technology areas. For applicants who need speed, Track One prioritized examination (37 C.F.R. § 1.102(e)) aims for a final disposition within roughly twelve months of being granted prioritized status, in exchange for an additional fee. Eligibility is defined by rule: original nonprovisional utility and plant applications filed under 35 U.S.C. § 111(a) with no more than four independent claims, thirty total claims, and no multiple dependent claims. Continuations, divisionals, and CIPs qualify as "original" applications for this purpose; reissue applications do not. Track One is well suited to a startup that needs an issued patent to close financing or to deter a fast-moving competitor. It is one of several acceleration routes: applicants can also use the (no-fee) accelerated examination support-document procedure, the Patent Prosecution Highway (PPH)—which leverages a favorable result in one office to speed examination in another participating office—and age- or health-based petitions to make special.

The Examination (Prosecution) Process

"Prosecution" is the term of art for the back-and-forth between an applicant and the USPTO that leads—if all goes well—to a granted patent. It is an administrative negotiation conducted in writing, governed by Title 37 and the agency's Manual of Patent Examining Procedure (MPEP).

What happens after I file? Your application is assigned a number and routed to an art unit—a group of examiners specializing in the relevant technology—and ultimately to a specific examiner. Most utility applications are published eighteen months after the earliest filing date for which a benefit is sought (35 U.S.C. § 122(b)), unless you both request non-publication and certify that you will not file abroad. (Pre-grant publication matters for more than transparency: it can give the patentee provisional rights to a reasonable royalty for certain pre-issuance infringement under 35 U.S.C. § 154(d).) The examiner reviews the claims against the prior art and the statutory requirements and issues a written "office action."

What is an office action, and how do I respond? An office action is the examiner's formal report. A non-final office action typically rejects some or all claims—commonly under § 102 (anticipation), § 103 (obviousness), § 101 (eligibility), or § 112 (written description, enablement, or indefiniteness)—and explains the basis for each rejection. You respond by amending claims, presenting arguments distinguishing the prior art, or both, usually within a three-month shortened statutory period that can be extended (for a fee) up to six months under 37 C.F.R. § 1.136(a). If the examiner is not persuaded, the next action is often made "final," which narrows your options but does not end the road. Because nearly every application receives at least one rejection, knowing how to read and answer an office action is a core skill; our companion guide on responding to patent office actions walks through the strategy in depth, and the obviousness guide linked above addresses the most common rejection type.

Amending claims correctly. Claim amendments must follow strict formatting rules under 37 C.F.R. § 1.121. Any amendment that changes, cancels, or adds a claim must include a complete listing of all claims ever presented, each marked with one of the permissible status identifiers: (Original), (Currently amended), (Canceled), (Previously presented), (New), (Not entered), and (Withdrawn) (and the combined "Withdrawn—currently amended"). These conventions let the examiner—and later a court—track exactly how the claims evolved. They matter beyond housekeeping: amendments made to overcome prior art can give rise to prosecution history estoppel, limiting how broadly the claim can later be read under the doctrine of equivalents (Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 535 U.S. 722 (2002)). Every amendment is therefore a strategic act, not a clerical one, and every argument you make to distinguish prior art can become a tool the accused infringer uses against you years later.

What if the examiner won't budge? After a final rejection you have several paths. You may file a request for continued examination (RCE) under 37 C.F.R. § 1.114 to buy another round of examination; you may appeal to the Patent Trial and Appeal Board (PTAB) under 35 U.S.C. § 134; or, before committing to a full appeal, you may use the Pre-Appeal Brief Conference Pilot Program. That program lets you file, together with a notice of appeal, a concise request (five pages or fewer, on Form PTO/SB/33) asking a panel of examiners to take a fresh look. Its purpose is to spare you the time and expense of a full appeal brief when the case is either clearly allowable or clearly not in condition for appeal. If a true appeal is warranted, the PTAB reviews the examiner's rejections on the written record, and an adverse decision can be appealed to the U.S. Court of Appeals for the Federal Circuit or challenged by civil action under 35 U.S.C. § 145.

How can I check the status of my application? The USPTO provides online access to application records through Patent Center (which has replaced the older PAIR systems). A private, authenticated view shows the full file history for applications associated with your customer number; a public view shows the same information once an application has published or issued. You can also contact the examiner directly or the agency's file information unit. If you hit a genuine roadblock and the normal channels—examiner, then the supervisory patent examiner (SPE)—have failed, the Ombudsman Program offers an escalation path, but it is meant to supplement those channels, not replace them. A well-timed examiner interview, conducted before or after a response, is often the single most effective way to break a logjam.

Administrative housekeeping. A few recurring procedural questions deserve quick answers. Power of attorney is established or corrected by filing the appropriate form (historically SB/81) and is reflected in the file's address and attorney/agent record; correspondence-address changes use a separate form (SB/122). Multiple applications can be tied to a single customer number to streamline correspondence and electronic notifications. The agency's e-Office Action program delivers notices electronically rather than by mail, which is faster and reduces the risk of lost or mis-docketed paper. Errors in an issued patent are fixed by a Certificate of Correction (35 U.S.C. §§ 254–255): the USPTO bears no fee for its own mistakes, while applicant errors require a fee and, for substantive changes, may require a reissue application under § 251 instead.

Costs and Fees

How much does it cost to get a patent? There is no single number, because the USPTO's fees vary by application type, by how you claim the invention, and by your entity size, and because government fees are only part of the picture. For a utility patent there are three basic categories of government fees, all set out in the fee schedule under 37 C.F.R. §§ 1.16–1.20:

  • The filing fees (a basic filing fee, a search fee, and an examination fee), which are due at filing and are not refundable even if no patent ever issues. As the USPTO explains, the filing fee pays for the service of examining the application, not for a patent.
  • The issue fee, paid only if the application is allowed.
  • Maintenance fees, paid after grant to keep a utility patent in force (discussed in the term-and-maintenance section below).

Excess-claims fees apply if you present more than three independent claims or more than twenty total claims, and various other fees (extensions of time, RCEs, petitions) can arise during prosecution. The USPTO also adjusts its fee schedule periodically—a substantial revision took effect in 2025—so always confirm current amounts on the agency's published schedule rather than relying on a number you read somewhere.

Crucially, government fees are typically the smaller part of the total. Attorney fees for preparing and prosecuting a quality utility application usually dwarf the USPTO's charges, because drafting a robust specification and claim set—and then negotiating them through examination—is skilled work. A simple mechanical invention may cost a few thousand dollars in attorney time to prepare; a complex software or biotech application can cost far more, plus the ongoing cost of responding to office actions. Budgeting for prosecution, not just filing, is essential. The companion FAQ's section on what a patent really costs walks through realistic budgeting from a business owner's perspective.

What are small entity and micro entity status? Congress reduced fees for smaller players. A small entity—broadly, an independent inventor, a small business concern, or a nonprofit—pays reduced filing, issue, and maintenance fees (35 U.S.C. § 41(h); 37 C.F.R. § 1.27). A micro entity, which must meet additional limits on income and prior filings (35 U.S.C. § 123; 37 C.F.R. § 1.29), pays even less. Following recent fee legislation, micro entity fees are now discounted by 80 percent and small entity fees by 60 percent relative to the standard (undiscounted) fees—a meaningful change from the older 75 percent and 50 percent figures that many older sources still quote. Claiming a discount you do not qualify for is a serious matter—an improper, deceptive small-entity assertion can even render a patent unenforceable—so confirm eligibility (and re-confirm it before each maintenance payment, since circumstances change).

How do I pay, and are fees refundable? Fees may be paid by USPTO deposit account, credit card, or electronic funds transfer. Sensitive payment details should never be embedded in publicly viewable documents. As noted, the basic filing fees are statutorily non-refundable; that is the price of examination itself. The issue fee is paid only on allowance, so an application that is abandoned before allowance simply never incurs it.

Provisional Applications, Disclosure, and Priority

What exactly does a provisional application do? A provisional application (35 U.S.C. § 111(b)) secures a filing date and lets you say "patent pending," but it is never examined, never published, and automatically goes abandoned twelve months after filing (35 U.S.C. § 119(e); the provisional is not eligible for the eighteen-month publication that applies to nonprovisionals). Its value is timing. In a first-inventor-to-file world (discussed next), the date you file can decide who gets the patent, so a provisional is a fast, lower-cost way to plant a flag while you continue development, seek funding, or test the market.

The catch that traps the unwary. A provisional only provides priority for subject matter it actually discloses well enough to satisfy the written-description and enablement requirements of 35 U.S.C. § 112(a). A bare, two-page provisional that gestures at an idea will not support broad claims later. Consider a worked example (hypothetical). Dana Lee files a thin provisional in January 2026 describing a "smart irrigation controller" in general terms. In December 2026 Dana files a nonprovisional with detailed claims to a specific moisture-sensing algorithm that the provisional never described. Those algorithm claims do not get the January 2026 date; they get the December date—and any prior art that appeared in between can now be used against them. The lesson: treat the provisional as a complete technical description, not a sketch. A strong invention disclosure prepared for your patent attorney is the raw material that lets counsel draft a provisional substantial enough to actually hold the early date.

Don't lose foreign rights in the twelve months. Public disclosure of your invention can destroy patent rights abroad even where a U.S. provisional preserves your U.S. position, because many countries apply absolute novelty with no grace period. If foreign protection might matter, treat the provisional year as a window to file a PCT application or foreign applications, and avoid public disclosure before you do. Beware too of the U.S. on-sale bar: under post-AIA § 102, a secret commercial sale or offer for sale more than a year before filing can still bar a patent, as the Supreme Court confirmed in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., 586 U.S. 123 (2019). A confidential supply agreement is not the safe harbor founders sometimes assume it is.

The America Invents Act and First-Inventor-to-File

No modern patent FAQ is complete without the Leahy–Smith America Invents Act (AIA) of 2011, the most significant overhaul of U.S. patent law in more than half a century. Two changes matter most to applicants.

First-inventor-to-file. For applications with an effective filing date on or after March 16, 2013, the United States moved from a first-to-invent system to a first-inventor-to-file system (35 U.S.C. § 102, as amended). Under the old regime, an inventor could sometimes overcome an earlier filer by proving an earlier date of invention. Under the AIA, with narrow exceptions, the inventor who files first generally prevails. This elevates filing speed to a strategic priority and is a principal reason provisional applications have become so popular—they are the cheapest way to lock in an early effective filing date.

The transition rule is more subtle than the headline date suggests. As the USPTO explains, an application is governed by the AIA's first-inventor-to-file provisions if it ever contained a claim with an effective filing date on or after March 16, 2013, or if it claims continuation, divisional, or CIP status from such an application. Neither filing a request for continued examination nor entering the national phase under 35 U.S.C. § 371 counts as filing a new application for this purpose. A handful of long-pending families therefore still operate under the pre-AIA rules, which is why the distinction continues to matter in practice.

A grace period, but a narrow one. The AIA preserves a one-year grace period in 35 U.S.C. § 102(b)(1): a disclosure made by the inventor (or by someone who obtained the subject matter from the inventor) less than one year before filing does not count as prior art against that inventor. There is also a parallel exception in § 102(b)(2) that disqualifies certain earlier-filed but later-published applications when the subject matter came from the inventor or was commonly owned. But this is a U.S. safety net, not a license to publish. Most foreign jurisdictions have no equivalent grace period, so a pre-filing disclosure that is forgiven in the United States can be fatal abroad. The safe practice remains: file first, disclose second.

Joint research agreements. The AIA carried forward the CREATE Act framework for collaborative research. A joint research agreement (JRA) is, per 35 U.S.C. § 100(h), a written contract, grant, or cooperative agreement between two or more parties to perform experimental, developmental, or research work in the field of the claimed invention. Under defined conditions (now reflected in § 102(b)(2)(C) and § 102(c)), parties to a JRA can avoid having one collaborator's work used as prior art against the other's claims—an important protection for university–industry and multi-company R&D partnerships. Getting the agreement in writing, in advance, is what unlocks the benefit.

International Protection and the PCT

Does a U.S. patent protect me abroad? No. The rights granted by a U.S. patent extend only throughout the territory of the United States and have no effect in any foreign country. To obtain protection elsewhere, you must pursue patents in each country or region where you want rights—either by filing directly in each national or regional patent office (for example, the European Patent Office for a clutch of European states) or by using an international filing system.

What is a PCT application? The Patent Cooperation Treaty (PCT), administered by the World Intellectual Property Organization (WIPO), is an international filing system with effect in more than 150 contracting states. The PCT does not grant an "international patent"—no such thing exists—but it dramatically simplifies the early stages. With a single international application, filed in one language at one receiving office, an applicant preserves the right to seek protection in any PCT member state. Critically, the PCT defers the large expense of foreign national filings: you generally have until thirty (or in some countries thirty-one) months from your earliest priority date to enter the "national phase" in the countries you ultimately choose. That delay—and the international search report and written opinion you receive along the way—buys time to assess commercial viability and the strength of your invention before committing to translations, local counsel, and national fees in many jurisdictions.

Here is how it fits together in practice (hypothetical). Suppose Acme Corp. files a U.S. provisional on June 1, 2026. It has twelve months to file a PCT application claiming priority to that provisional. Filing the PCT in May 2027 then gives Acme until roughly December 2028 (thirty months from the June 2026 priority date) to decide which countries are worth the cost of national-phase entry. Acme thus spreads a series of expensive decisions over more than two years instead of front-loading them, all while keeping a single early priority date.

Foreign filing licenses. Before you file abroad, U.S. law requires a foreign filing license for inventions made in the United States, to allow a national-security review (35 U.S.C. §§ 181–188; 37 C.F.R. part 5). In most cases the license issues automatically: filing a U.S. application starts the clock, and 35 U.S.C. § 184 grants an implicit license six months after the U.S. filing if no secrecy order has issued. The USPTO's Licensing and Review unit administers this regime, can expedite a petition for a license (it aims to act within about three business days, faster if a bar date is imminent), and manages secrecy orders. Two points of caution: a foreign filing license covers the act of filing abroad and related activities, but it does not authorize sending technical information overseas merely to prepare a U.S. filing; and the license is not country-specific, so applicants must still comply with export-control and sanctions rules administered by other agencies (such as the Department of Commerce's Bureau of Industry and Security and the Treasury Department's Office of Foreign Assets Control). Whether a license is even required in a given fact pattern is a legal judgment that rests with the applicant, not with the USPTO. For broader strategy on protecting and enforcing rights overseas, the USPTO's IP Attaché program is a useful starting point, and our guide on global patent litigation strategies covers cross-border enforcement.

Post-Grant Proceedings: Challenging and Defending a Patent

The AIA created a suite of adversarial proceedings before the PTAB that let third parties challenge issued patents without the cost of district-court litigation—and that give patent owners a forum to defend them.

What is inter partes review (IPR)? IPR, effective September 16, 2012, replaced the older inter partes reexamination as the principal way a third party can challenge a patent's validity at the USPTO (35 U.S.C. §§ 311–319). A petitioner may challenge claims only on novelty (§ 102) and obviousness (§ 103) grounds, and only on the basis of patents and printed publications. The Board institutes review if the petitioner shows a reasonable likelihood of prevailing on at least one challenged claim, and the proceeding is meant to reach a final written decision within roughly a year of institution. IPR has become a central feature of patent disputes: accused infringers routinely file IPR petitions in parallel with district-court litigation, and the two tracks interact in complex ways. The most important interaction is statutory estoppel: under 35 U.S.C. § 315(e), a petitioner who obtains a final written decision is barred from later asserting, in the PTAB, district court, or ITC, any ground it "raised or reasonably could have raised" during the IPR. That estoppel is a double-edged sword—it disciplines petitioners to put their best art forward—and the Supreme Court's holding in SAS Institute Inc. v. Iancu, 138 S. Ct. 1348 (2018), that the Board must decide every challenged claim if it institutes, broadened the estoppel's reach. The USPTO publishes the common pitfalls petitioners stumble over—improper claim charts that smuggle in argument, failure to construe disputed claim terms, mismatched or mis-numbered exhibits, missing identification of related matters or counsel, and service defects—which together illustrate how technical and unforgiving these filings are. For the litigation side of the story, see our comprehensive guide to patent infringement litigation.

Covered business method (CBM) review—now historical. The AIA also created a transitional program for covered business method patents—broadly, patents claiming a method or apparatus for data processing used in the administration of a financial product or service, excluding "technological inventions." CBM review allowed challenges on a wider set of grounds than IPR, and parties could settle (a settlement terminates the proceeding as to the petitioner, and the Board may terminate the proceeding or issue a final written decision). But the program was expressly transitional: Congress set it to sunset eight years after its September 16, 2012 effective date, and the USPTO accordingly stopped accepting new CBM petitions on or after September 16, 2020. CBM review is therefore no longer available for new challenges, though its decisions remain part of the case law. Today, challenges to financial-software patents proceed through IPR or post-grant review.

Post-grant review (PGR) and derivation. Rounding out the AIA proceedings, post-grant review (35 U.S.C. §§ 321–329) allows a broader validity challenge—including on eligibility under § 101 and disclosure under § 112—but only within nine months of grant and only for AIA (first-inventor-to-file) patents. Derivation proceedings (§ 135) replaced the old interference practice and resolve disputes over whether an earlier applicant derived the invention from a later one. Inventors should know that a patent owner who is an individual may appear pro se as the respondent in these proceedings, though the technical demands make experienced counsel advisable. One more wrinkle worth flagging: even when a petition clears the statutory threshold, the Board retains discretion to deny institution—for example where parallel district-court litigation is far advanced—so a meritorious petition is not a guaranteed one.

Patent Term and Maintenance

How long does patent protection last? For utility and plant applications filed on or after June 8, 1995, the term runs twenty years from the earliest U.S. filing date to which the application claims priority (35 U.S.C. § 154(a)(2)). Because that clock starts at filing but the patent is not enforceable until it issues, the effective period of exclusivity depends on how long examination takes—which is why patent term adjustment (35 U.S.C. § 154(b)) can add days to compensate for certain USPTO delays, and patent term extension (35 U.S.C. § 156) can extend terms for products delayed by regulatory review, such as pharmaceuticals. Note that a terminal disclaimer filed to overcome obviousness-type double patenting will cap a patent's term to that of an earlier related patent, sometimes giving back the very days a term adjustment had added.

Design patents follow different rules. A design patent has a term of fifteen years from grant for applications filed on or after May 13, 2015 (35 U.S.C. § 173), with no maintenance fees. Plant patents run twenty years from filing and likewise carry no maintenance fees. The interplay between design and utility protection—when you can and should pursue both for a single product—raises distinct strategic and double-patenting questions covered in our guide on the intersection of design and utility patents. Design-patent strategy also shifted recently: the Federal Circuit's en banc decision in LKQ Corp. v. GM Global Technology Operations LLC, 102 F.4th 1280 (Fed. Cir. 2024), discarded the old rigid Rosen-Durling obviousness test, a change we unpack in The LKQ Decision.

Maintenance fees. A utility patent will lapse before the end of its term unless the owner pays maintenance fees at three windows after grant: at 3½, 7½, and 11½ years (35 U.S.C. § 41(b); 37 C.F.R. § 1.20(e)–(g)). There are no maintenance fees for design or plant patents. The fees escalate at each stage, on the theory that an owner should pay more to keep alive a patent that has proven valuable. Each payment has a grace period (a six-month window with a surcharge), and missing the window causes the patent to expire—though a patent that lapsed unintentionally can sometimes be revived by petition under 37 C.F.R. § 1.378. Diligent docketing of these dates is one of the most important, and most mundane, tasks in portfolio management; a single missed maintenance fee can extinguish a patent worth far more than the fee. Entity status should be reconfirmed at each payment, because a company that has grown out of small or micro entity status must pay the full amount.

Patent Assignment, Ownership, and Recording

Inventorship versus ownership. As noted earlier, only inventors can be named on a patent, but they need not own it. In the employment setting, employees who invent in the scope of their work typically assign their rights to the employer, often under a pre-existing invention assignment agreement. The application is filed naming the inventors, while the assignee is recorded as owner. Getting assignments executed early and correctly avoids painful gaps in the chain of title—gaps that surface, inconveniently, during financings, acquisitions, and litigation. Drafting matters too: the Supreme Court's decision in Stanford v. Roche, 563 U.S. 776 (2011), is a famous lesson that an agreement promising to assign ("agree to assign") can be defeated by a later present assignment ("hereby assign"), so language is not interchangeable.

Recording and searching assignments. The USPTO records assignments and other documents affecting title, and these records are publicly searchable through the agency's Patent Assignment Search tool. Recording is not, strictly speaking, what transfers ownership—the assignment document does that—but recording protects the assignee against a subsequent bona fide purchaser (35 U.S.C. § 261) much as recording a deed protects a property buyer, so it should be done promptly. If incorrect assignee information appears on an issued patent, the fix is a Certificate of Correction; whether a fee or petition is required depends on whether the error was the USPTO's or the applicant's.

Enforcement and Commercialization Basics

What rights does a patent actually give me, and how are they enforced? A patent gives its owner the right to exclude others from making, using, selling, offering to sell, or importing the claimed invention without authorization (35 U.S.C. § 271). The owner enforces that right by suing for infringement in federal district court—patent cases arise under federal law and belong in the federal courts, with appeals heard by the U.S. Court of Appeals for the Federal Circuit. Remedies can include injunctive relief (subject to the equitable test of eBay Inc. v. MercExchange, L.L.C., 547 U.S. 388 (2006)) and damages no less than a reasonable royalty (35 U.S.C. §§ 283–284), and enhanced damages for willful infringement and attorney fees in exceptional cases (§§ 284–285). The USPTO grants patents; it does not enforce them. Litigation is a separate, and often expensive, undertaking that turns on claim construction (the court's interpretation of what the claims mean, a question of law under Markman v. Westview Instruments, Inc., 517 U.S. 370 (1996)) and on proof that the accused product or method meets every element of at least one claim. For the threshold question of what counts as infringement, see What Constitutes Patent Infringement.

Commercializing without litigating. Many patent owners never sue. They instead monetize through licensing—granting others the right to practice the invention in exchange for royalties or fees. Licensing requires its own discipline: valuing the patent, structuring royalties, allocating improvements and enforcement obligations, and negotiating the key business terms. Our guide on licensing your patent, from valuation to term sheet walks through that process. The USPTO itself plays only a marketing-adjacent role: it will, for a fee, publish in the Official Gazette a notice that a patent is available for license or sale, but it cannot advise on or broker the underlying business transactions, and it does not vet would-be "invention promotion" firms—an area where independent inventors should exercise real caution.

A note on enforcement before you sell. Before launching a product, prudent companies confirm not only that they can obtain a patent but that they will not infringe someone else's. That is the freedom-to-operate question referenced at the outset, and it is genuinely independent of patentability. You can hold a valid patent on an improvement and still infringe the broader patent on the underlying technology. Sorting this out before, rather than after, a launch is far cheaper.

Working With a Patent Attorney or Agent

Do I need a patent attorney or agent? You are legally permitted to file pro se—on your own behalf—but the USPTO itself strongly recommends retaining a registered patent attorney or patent agent. The reason is that drafting claims and a supporting specification is genuinely difficult, and mistakes are often uncorrectable. A claim drafted too narrowly leaves competitors free to design around it; a specification that fails to support the claims can sink them under § 112; an inartful description can forfeit valuable scope forever. The cost of competent drafting is almost always small next to the cost of a patent that turns out to be worthless or unenforceable.

Attorney versus agent. Both registered patent attorneys and registered patent agents have passed the patent bar and may prepare and prosecute applications before the USPTO. The difference is that a patent attorney is also licensed to practice law generally and can therefore advise on infringement, litigation, licensing, and other legal matters that fall outside the agency's procedural work; an agent's authority is limited to USPTO prosecution. Practitioners are listed in the USPTO's roster maintained by the Office of Enrollment and Discipline (OED), which also sets the requirements for the registration examination.

How to make counsel effective. The single most useful thing an inventor can do is arrive prepared. A thorough invention disclosure—describing what the invention is, how it works, what problem it solves, how it differs from existing approaches, and what variations the inventor envisions—lets the attorney draft a stronger, broader application faster, which usually means lower cost and better protection. Again, our guide on preparing an invention disclosure is the place to start. Bring any prior art you are aware of (you have a duty of candor to disclose material prior art to the USPTO under 37 C.F.R. § 1.56, the breach of which can lead to a finding of inequitable conduct that renders the entire patent unenforceable), the dates of any public disclosures or sales, and clear documentation of who contributed what to the conception of the invention.

Key Takeaways

  • A patent is a federal, limited-term right to exclude, granted in exchange for full public disclosure. It is not a right to practice, and it has no effect outside the United States.
  • Only the actual human inventors may be named, but they need not own the patent; employers commonly own by assignment, and the assignment language matters (Stanford v. Roche). Inventorship is determined claim-by-claim and must be correct.
  • Patentable utility inventions must be eligible subject matter and must be useful, novel (§ 102), nonobvious (§ 103), and adequately disclosed and claimed (§ 112). Obviousness and, for software, eligibility under Alice are the most common stumbling blocks.
  • Since March 16, 2013, the United States awards patents on a first-inventor-to-file basis. File early; a provisional application is the cheapest way to lock in a priority date—provided it actually describes the invention—and beware the on-sale bar even for confidential sales.
  • The PCT defers and consolidates the cost of seeking foreign protection but grants no international patent. A foreign filing license is required before filing abroad.
  • Costs include non-refundable government filing fees, an issue fee, and escalating maintenance fees at 3½, 7½, and 11½ years for utility patents, plus attorney fees that usually exceed the government's charges. Small and micro entities pay substantially reduced fees.
  • Issued patents can be challenged at the PTAB through IPR (with § 315(e) estoppel) and, for AIA patents, PGR; CBM review has sunset. Patents are enforced by the owner in federal court, not by the USPTO.
  • Retain a registered patent attorney or agent, and come prepared with a complete invention disclosure and a candid account of prior art and inventorship.

Frequently Asked Questions

Can I patent an idea? No. A patent requires a concrete, enabled invention—something a skilled person could actually make and use from your disclosure. A mere idea, concept, or suggestion is not patentable. The work of patent drafting is largely the work of turning an idea into a sufficiently described, claimed invention.

How long does it take to get a patent? It varies widely by technology, but average pendency commonly runs around two years from filing, and longer in crowded fields. Track One prioritized examination targets a final disposition within about twelve months for an additional fee, and applicants can sometimes shorten the path through interviews, the Patent Prosecution Highway, and well-crafted responses.

Will a provisional application protect me abroad and keep my idea secret? A provisional is never published and never examined, so it remains confidential unless you later disclose its contents, and it secures a U.S. priority date. But it only protects subject matter it adequately describes, it expires in twelve months, and it does not itself preserve foreign rights—public disclosure before you file abroad can still destroy patentability in countries without a grace period.

Is a patent search required before filing? No, but it is strongly advisable. A search reveals the prior-art landscape, informs claim drafting, and can save you from prosecuting a doomed application. Free help is available at Patent and Trademark Resource Centers, and the USPTO's Patent Public Search tool is free online; for high-stakes filings, a professional search commissioned through counsel is well worth the cost.

What is the difference between filing fees and maintenance fees? Filing fees are paid up front to have the application examined and are non-refundable regardless of outcome. Maintenance fees are paid after a utility patent issues—at 3½, 7½, and 11½ years—to keep it in force; design and plant patents have none. Missing a maintenance fee can let a valuable patent lapse.

Can the USPTO help me market or sell my invention? No. The agency examines and grants patents; it does not advise on or broker business deals. It will publish, for a fee, a notice in the Official Gazette that a patent is available for license or sale, and it offers resources for independent inventors, but commercialization is your responsibility—handled, if you wish, through licensing or sale with the help of counsel.

Should I read this article or its companion FAQ first? If you are still deciding whether to patent—weighing cost, value, and alternatives like trade secrets—start with the consumer-friendly Patent FAQs: Frequently Asked Questions About Patents. If you have decided to file and want to understand the USPTO machinery, you are already in the right place.

Related Articles

This article is provided by mclaw.io for general informational purposes only and does not constitute legal advice. Patent law is complex, fact-specific, and subject to change, and government fees, procedures, and deadlines are periodically revised. Reading this guide does not create an attorney–client relationship. For advice about your specific situation, including any filing or maintenance deadline, consult a registered patent attorney or agent or other qualified counsel.